{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:26:27Z","timestamp":1780385187644,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.npep.2005.04.004","type":"journal-article","created":{"date-parts":[[2005,9,10]],"date-time":"2005-09-10T11:39:42Z","timestamp":1126352382000},"page":"515-523","source":"Crossref","is-referenced-by-count":5,"title":["Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity"],"prefix":"10.1016","volume":"39","author":[{"given":"E.","family":"Obuchowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Krysiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Wieronska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smialowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.S.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2005.04.004_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-2999(95)00571-4","article-title":"Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels","volume":"294","author":"Antkiewicz-Michaluk","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0773.1988.tb01859.x","article-title":"Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats","volume":"62","author":"Arnt","year":"1988","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.npep.2005.04.004_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(87)90144-0","article-title":"Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats","volume":"133","author":"Arnt","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(97)00283-7","article-title":"Differential modulation of NMDA \u2013 stimulated [3H]dopamine release from rat striatum by neuropeptide Y and \u03c3 receptor ligands","volume":"760","author":"Ault","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib5","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1523\/JNEUROSCI.18-23-10207.1998","article-title":"Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation","volume":"18","author":"Bernard","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2005.04.004_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-328X(02)00555-7","article-title":"Increased neuropeptide Y mRNA expressoin in striatum in Parkinson\u2019s disease","volume":"110","author":"Cannizarro","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib7","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/0024-3205(88)90372-4","article-title":"Concurrent treatment with benztropine and haloperidol attenuates development of behavioural hypersensitivity but not dopamine receptor proliferation","volume":"42","author":"Carvey","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2005.04.004_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-4522(90)90221-O","article-title":"The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum","volume":"39","author":"Delfs","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2005.04.004_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0306-4522(86)90056-4","article-title":"Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. I. Radioimmunoassay and chromatographic characterisation","volume":"18","author":"De Quidt","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2005.04.004_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/syn.890180303","article-title":"Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptics-induced dyskinesias","volume":"18","author":"Egan","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2005.04.004_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(92)90716-M","article-title":"Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin","volume":"581","author":"Engber","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(99)00569-5","article-title":"Enhanced striatal dopamine D2 receptor-induced [35S]GTP\u03b3S binding after haloperidol treatment","volume":"382","author":"Geurts","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/1097-4547(20000815)61:4<458::AID-JNR13>3.0.CO;2-I","article-title":"Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum","volume":"61","author":"Gruber","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2005.04.004_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01245130","article-title":"Effects of centrally administered neuropeptide Y (NPY) and NPY13\u221236 on the brain monoaminergic systems of the rat","volume":"79","author":"Heilig","year":"1990","journal-title":"J. Neural. Transm. [GenSect]"},{"key":"10.1016\/j.npep.2005.04.004_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1471-4159.1974.tb11589.x","article-title":"Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity","volume":"22","author":"Horn","year":"1974","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2005.04.004_bib16","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0028-3908(99)00199-9","article-title":"Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304","volume":"39","author":"Kask","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2005.04.004_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(95)98374-8","article-title":"Striatal interneurones: chemical, physiological and morphological characterization","volume":"18","author":"Kawaguchi","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.npep.2005.04.004_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0306-4522(88)90101-7","article-title":"Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by striatal neurons","volume":"26","author":"Kerkerian","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2005.04.004_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0361-9230(92)90178-Z","article-title":"Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum","volume":"28","author":"Kerkerian-Le Goff","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2005.04.004_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(94)90081-7","article-title":"Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements","volume":"646","author":"Knable","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/syn.890120103","article-title":"Dopamine supersensitivity and D1\/D2 synergism are unrelated to changes in striatal receptor density","volume":"12","author":"LaHoste","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2005.04.004_bib22","first-page":"175","article-title":"Regulation of neuropeptide Y gene expression in rat brain","volume":"611","author":"Lindefors","year":"1990","journal-title":"Ann. N.Y. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2005.04.004_bib23","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/0024-3205(87)90532-7","article-title":"Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats","volume":"41","author":"Longoni","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2005.04.004_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(93)90448-Q","article-title":"Dopamine D1 receptor stimulation but not dopamine D2 receptor attenuates haloperidol-induced behavioural supersensitivity and receptor up ulation","volume":"231","author":"Marin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(96)00461-1","article-title":"Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior","volume":"731","author":"Marin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/BF02532423","article-title":"Metabolism and functions of neuropeptide Y","volume":"21","author":"Medeiros","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.npep.2005.04.004_bib27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0024-3205(89)90553-5","article-title":"Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors","volume":"44","author":"Meller","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2005.04.004_bib28","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1523\/JNEUROSCI.20-20-07798.2000","article-title":"Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias","volume":"20","author":"Meredith","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2005.04.004_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(92)91268-J","article-title":"Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen","volume":"593","author":"Midgley","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(94)90400-6","article-title":"Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions","volume":"251","author":"Midgley","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0361-9230(90)90071-7","article-title":"Effect of haloperidol on immunoreactive neuropeptide Y in rat cerebral cortex and basal ganglia","volume":"25","author":"Miyake","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2005.04.004_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0091-3057(94)90332-8","article-title":"Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats","volume":"48","author":"Moore","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2005.04.004_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(99)00666-4","article-title":"Differential effect of quinpirole in neuroleptic-pretreated rats \u2013 role of \u03b11-adrenoceptor","volume":"384","author":"Obuchowicz","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0047-1","article-title":"Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice","volume":"110","author":"Obuchowicz","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.npep.2005.04.004_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neubiorev.2004.08.006","article-title":"Does neuropeptide Y(NPY) mediate the effects of psychotropic drugs?","volume":"28","author":"Obuchowicz","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2005.04.004_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0143-4179(98)90074-9","article-title":"Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum","volume":"32","author":"Obuchowicz","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2005.04.004_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0924-977X(98)00007-8","article-title":"Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity in the nucleus accumbens of rat","volume":"9","author":"Obuchowicz","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib38","first-page":"299","article-title":"Neuronal basis of neuroleptics-induced extrapyramidal side effects","volume":"54","author":"Ossowska","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00498552","article-title":"Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain","volume":"299","author":"\u00d6hman","year":"1977","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib40","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.npep.2005.04.004_bib41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0301-0082(94)90025-6","article-title":"The nucleus accumbens as a complex of functionally distinct neuronally ensembles: an integration of behavioural, electrophysiological and anatomical data","volume":"42","author":"Pennartz","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.npep.2005.04.004_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00634463","article-title":"Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride","volume":"99","author":"Prosser","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.npep.2005.04.004_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0143-4179(95)90018-7","article-title":"Increases in cortical neuropeptide Y and somatostatin concentration following haloperidol-depot treatment in rats","volume":"29","author":"Sakai","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2005.04.004_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00228127","article-title":"Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway","volume":"81","author":"Salin","year":"1990","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0306-4522(94)90063-9","article-title":"Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-d-aspartate antagonist dizocilpine maleate","volume":"61","author":"Salin","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2005.04.004_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0024-3205(89)90600-0","article-title":"Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D2 but not dopamine D1 receptors","volume":"44","author":"See","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2005.04.004_bib47","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0028-3908(91)90022-4","article-title":"In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists","volume":"30","author":"See","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2005.04.004_bib48","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0306-4522(99)00393-0","article-title":"Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala","volume":"94","author":"Smialowska","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2005.04.004_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0006-8993(87)90702-5","article-title":"The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from caudate nucleus","volume":"411","author":"Tatsuoka","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2005.04.004_bib50","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/BF00175707","article-title":"Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action","volume":"342","author":"Timmerman","year":"1990","journal-title":"Naunyn\u2013Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(92)90091-H","article-title":"Effects of intracerebral quinpirole on locomotion in rats","volume":"214","author":"Van Hartesveldt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2005.04.004_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3940(89)90667-8","article-title":"Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y containing neurons in the rat striatum","volume":"100","author":"Vuillet","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2005.04.004_bib53","first-page":"113","article-title":"Haloperidol and apomorphine differentially affect neuropeptidase activity","volume":"277","author":"Waters","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2005.04.004_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-3057(88)90442-X","article-title":"Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?","volume":"30","author":"White","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2005.04.004_bib55","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1073\/pnas.83.24.9827","article-title":"Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain","volume":"83","author":"Young","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341790500051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341790500051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:33:46Z","timestamp":1553099626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341790500051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S014341790500051X"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2005.04.004","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}